Kaufman Beth D, Nagle Monica L, Levine Selena R, Vijaynathan Nirmala, Hanna Brian D, Paridon Stephen, Ravishankar Chitra, Chrisant Maryanne K
Thoracic Organ Transplant Program, Children's Hospital of Philadelphia, and Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-4399, USA.
J Heart Lung Transplant. 2008 May;27(5):508-13. doi: 10.1016/j.healun.2008.01.026.
Body habitus assessment (BHA), be it wasted or obese, is a useful marker of nutritional status and overall medical condition. Wasting and obesity pre-heart transplant adversely affects outcomes in adults. The utility of BHA as a prognostic factor in children post-transplant is unknown.
Weight and height at listing and standard growth charts were used to determine the ideal body weight (%IBW) and percentiles for body mass index for age (BMI%) and weight-for-length (W:L%). Wasting was defined as <90%IBW and/or <or=5th percentile for BMI% or W:L%. Obesity was defined as >120%IBW and/or >or=95th percentile BMI% or W:L%. Outcomes of cohorts based on these criteria were compared.
From June 1990 to December 2006, 180 children, aged 5.81 +/- 6 years, were listed for transplant. Wasting occurred in 66 (37%) and obesity in 22 (12%) children, without differences between diagnoses of cardiomyopathy or congenital heart disease. %IBW was a prognostic factor for survival post-transplant on multivariate analysis: obese patients had a hazard ratio (HR) of 3.82 (95% confidence interval [CI] 1.81 to 8.06) compared with normal BHA (p < 0.001). Wasting had a survival advantage compared with normal BHA (HR 0.51, 95% CI 0.27 to 0.94, p = 0.032). There were no significant differences between cohorts in incidence of infections, first-year rejections or graft vasculopathy.
Abnormal BHA at listing was a prognostic factor for survival post-transplant. Obese children had increased mortality, but wasting did not adversely affect post-transplant survival in our population. Body habitus assessment may risk-stratify children at listing, potentially providing a complex target for intervention.
身体体型评估(BHA),无论是消瘦还是肥胖,都是营养状况和整体健康状况的有用指标。心脏移植前的消瘦和肥胖会对成人的预后产生不利影响。BHA作为儿童移植后预后因素的效用尚不清楚。
利用登记时的体重和身高以及标准生长图表来确定理想体重(%IBW)、年龄别体重指数百分位数(BMI%)和身长体重比(W:L%)。消瘦定义为<90%IBW和/或BMI%或W:L%<或=第5百分位数。肥胖定义为>120%IBW和/或BMI%或W:L%>或=第95百分位数。比较基于这些标准的队列的结果。
从1990年6月至2006年12月,180名年龄为5.81±6岁的儿童登记接受移植。66名(37%)儿童出现消瘦,22名(12%)儿童出现肥胖,心肌病或先天性心脏病诊断之间无差异。在多变量分析中,%IBW是移植后生存的预后因素:与正常BHA相比,肥胖患者的风险比(HR)为3.82(95%置信区间[CI]1.81至8.06)(p<0.001)。与正常BHA相比,消瘦具有生存优势(HR 0.51,95%CI 0.27至0.94,p = 0.032)。各队列在感染发生率、第一年排斥反应或移植物血管病变方面无显著差异。
登记时BHA异常是移植后生存的预后因素。肥胖儿童死亡率增加,但消瘦对我们研究人群的移植后生存没有不利影响。身体体型评估可能会在登记时对儿童进行风险分层,潜在地提供一个复杂的干预目标。